Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Up 0.9% – Time to Buy?
by Michael Walen · The Markets DailyBayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shot up 0.9% during trading on Tuesday . The stock traded as high as €48.48 and last traded at €48.48. 1,532,797 shares traded hands during mid-day trading, The stock had previously closed at €48.04.
Bayer Aktiengesellschaft Trading Up 0.9%
The company has a market cap of $48.94 billion, a P/E ratio of -55.62, a P/E/G ratio of 36.39 and a beta of 0.83. The company has a quick ratio of 0.72, a current ratio of 1.04 and a debt-to-equity ratio of 129.90. The business has a 50-day moving average price of €47.08 and a two-hundred day moving average price of €42.24.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.